Last deal

$1.21M
Local Amount - JPY 180M

Amount

Debt Financing

Stage

18.03.2024

Date

3

all rounds

$2.06M

Total amount

date founded

Financing round

General

About Company
United Immunity develops and sells pharmaceuticals for cancer immunotherapy.

Industry

Sector :

Subsector :

founded date

27.11.2017

Number of employees

Company Type

For Profit

Last funding type

Debt Financing

IPO status

Private

Description

The company specializes in researching, developing, manufacturing, and selling combination immunotherapies to support cancer treatment, with a specific focus on cold tumors. United Immunity's products aim to improve the quality of life for cancer patients by providing them with proper treatment.
Contacts

location

Contact Email

Phone number

Social url

Legal Names

Legal name

United Immunity, Co., Ltd.
Similar Companies
1000
Vaccinogen

Vaccinogen

Vaccinogen manufactures vaccines and immunotherapeutic products for cancers and infectious diseases.

Sector

Pharmaceuticals and Biotechnology

Subsector

Pharmaceuticals

Location

Frederick, MD, USA

total rounds

5

total raised

$99.05M
CimCure

CimCure

CimCure is dedicated to creating and advancing a groundbreaking category of dynamic cancer immunotherapies.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Keywords

Biotechnology, Health Care, Medical

Location

Amsterdam, Netherlands

total rounds

1

total raised

$5.35M
Inimmune

Inimmune

Inimmune is a biotech company developing immunotherapeutics for various diseases.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Keywords

Biotechnology, Health Care, Pharmaceuticals

Location

Missoula, MT, USA

total rounds

2

total raised

$22.59M
ImmVirX

ImmVirX

ImmVirX develops oncolytic viruses for cancer immunotherapy.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Location

New Lambton NSW 2305, Australia

total rounds

3

total raised

$50M

Financials

Funding Rounds
6
3

Number of Funding Rounds

$2.06M

Money Raised

Their latest funding was raised on 18.03.2024. Their latest investor Aozora Corporate Investment. Their latest round Debt Financing

Date 
Funding Round 
Investors 
Money Raised 
Lead 
18.03.2024
1
$1.21M
Local Amount - JPY 180M
11.09.2023
3
01.03.2021
1
Aozora Corporate Investment

Aozora Corporate Investment

Aozora Corporate Investment is a Tokyo-based corporate venture capital firm.

Sector

Investment Banking and Brokerage Services

Subsector

Asset Managers and Custodians

Keywords

Financial Services, Finance, Venture Capital

Location

Tokyo, Japan

count Of Investments

18
Co-Investors
Investors
8
2

Number of lead investors

8

Number of investors

Investor 
Lead 
Round 
Partners 
Yes
Debt Financing
No
Venture - Series Unknown
No
Venture - Series Unknown
Aozora Corporate Investment

Aozora Corporate Investment

Aozora Corporate Investment is a Tokyo-based corporate venture capital firm.

Sector

Investment Banking and Brokerage Services

Subsector

Asset Managers and Custodians

Keywords

Financial Services, Finance, Venture Capital

Location

Tokyo, Japan

count Of Investments

18
Toho Holdings

Toho Holdings

Toho Holdings is a Japanese company that focuses on pharmaceutical wholesale, dispensing pharmacy, and manufacturing businesses.

Sector

Pharmaceuticals and Biotechnology

Subsector

Pharmaceuticals

Keywords

Pharmaceuticals, Manufacturing, Medical

Location

Tokyo, Japan

count Of Investments

10
Saisei Ventures

Saisei Ventures

Saisei Ventures is a leading venture capital firm focused on early-stage companies in the biotechnology sector.

Sector

Investment Banking and Brokerage Services

Subsector

Asset Managers and Custodians

Keywords

Venture Capital, Biotechnology

Location

Cambridge, MA, USA

count Of Investments

6

People

Founders
1
Harada Naozumi
Harada Naozumi

Harada Naozumi

current job

United Immunity
United Immunity

Harada Naozumi

Employee Profiles
1
Harada Naozumi

Harada Naozumi

Founder, Representative Director , Chief Executive Officer & Chief Technology Officer

Activity

Recent News
0